Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28864144 | 0.88 | ALDH1A1 (0.45) | ALDH1A1TSHR | |
| SCHEMBL13807556 | 0.87 | ALDH1A1 (0.53) | ALDH1A1TSHRTP53CYP3A4MAPK1 | |
| SCHEMBL27786768 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL28202396 | 0.84 | ALDH1A1 (0.57) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL2221313 | 0.81 | ALDH1A1 (0.61) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL4924463 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL27736633 | 0.81 | ALDH1A1 (0.53) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL27736584 | 0.80 | ALDH1A1 (0.55) | ALDH1A1TSHRTP53CYP3A4 | |
| SCHEMBL12431464 | 0.80 | TSHR (0.39) | ALDH1A1TSHR | |
| SCHEMBL3874486 | 0.80 | TSHR (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12241010-B2 | Perovskite color converter and method of manufacturing the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-03-04 | — | — | US | disclosed |
| US-12134089-B2 | Multimodal chromatographic media for protein separation | DIONEX CORPORATION | 2024-11-05 | — | — | US | disclosed |
| US-12091597-B2 | Method for preparing quantum dot film, quantum dot film prepared thereby, and wavelength conversion sheet and display comprising same | INNO QD CO., LTD (KR) | 2024-09-17 | — | — | US | disclosed |
| WO-2024090759-A1 | QUANTUM DOT INK COMPOSITION, DEVICE USING SAME, AND DISPLAY DEVICE COMPRISING SAME | (주)이노큐디 | 2024-05-02 | — | — | WO | disclosed |
| CN-111601841-B | Method for manufacturing quantum dot film, quantum dot film manufactured thereby, wavelength conversion sheet including the same, and display | 株式会社尹诺丘迪 | 2023-07-07 | — | — | CN | disclosed |
| CN-112424268-B | Method for preparing quantum dot film, quantum dot film prepared thereby, wavelength conversion sheet comprising quantum dot film, and display | 株式会社尹诺丘迪 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023068664-A1 | QUANTUM DOT FILM COMPRISING QUANTUM DOT COMPOSITE, AND WAVELENGTH CONVERSION SHEET FOR DISPLAY | (주)이노큐디 | 2023-04-27 | — | — | WO | disclosed |
| US-11634627-B2 | Method for manufacturing quantum dot film comprising encapsulated quantum dots uniformly dispersed therein, quantum dot film manufactured thereby and wavelength conversion sheet and display comprising same | INNO QD CO., LTD (KR) | 2023-04-25 | — | — | US | disclosed |
| CN-109746055-B | Sulfonamide-based anion exchange resins | 戴安公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-111116985-B | Chlorinated fatty acid methyl ester composite stabilizer and preparation method thereof | 山东振曦新材料科技有限公司 | 2022-09-09 | — | — | CN | disclosed |
| WO-2009148829-A2 | METHOD FOR TREATING HYDROCARBON-BEARING FORMATIONS WITH FLUORINATED EPOXIDES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009148831-A2 | METHODS OF TREATING A HYDROCARBON-BEARING FORMATION, A WELL BORE, AND PARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-12-10 | — | — | WO | disclosed |
| WO-2009137275-A1 | FUNCTIONALIZED SUBSTRATES WITH ION-EXCHANGE PROPERTIES | DIONEX CORPORATION (US) | 2009-11-12 | — | — | WO | disclosed |
| US-20090277838-A1 | Functionalized substrates with ion-exchange properties | DIONEX CORPORATION (US) | 2009-11-12 | — | — | US | disclosed |
| EP-0964878-B1 | HYDROLYTICALLY STABLE RESINS FOR USE IN ANION-EXCHANGE CHROMATOGRAPHY | DIONEX CORP (US) | 2007-09-12 | — | — | EP | disclosed |
| EP-0964878-A4 | HYDROLYTICALLY STABLE RESINS FOR USE IN ANION-EXCHANGE CHROMATOGRAPHY | DIONEX CORP (US) | 2004-12-22 | — | — | EP | disclosed |
| EP-0964878-A1 | HYDROLYTICALLY STABLE RESINS FOR USE IN ANION-EXCHANGE CHROMATOGRAPHY | DIONEX CORPORATION (US) | 1999-12-22 | — | — | EP | disclosed |
| US-5936003-A | RESIN SUPPORT PARTICLES AND ANION EXCHANGE COMPOUNDS ATTACHED WHEREIN THE ANION-EXCHANGE COMPOUNDS COMPRISE AN INTERNAL REACTIVE GROUP, WHICH MAY BE AN ESTER, KETONE OR AMIDE GROUP, AND A TERMINAL QUATERNARY AMMONIUM SALT WHICH FUNCTIONS AS AN | DIONEX CORPORATION (US) | 1999-08-10 | — | — | US | disclosed |
| US-5925253-A | SYNTHETIC RESIN STATIONARY PHASE LINKED TO QUATERNIZED ANION-EXCHANGE SITES THROUGH REACTIVE GROUP AND ELONGATED LINKING ATOM CHAIN | DIONEX CORPORATION (US) | 1999-07-20 | — | — | US | disclosed |
| WO-1998039367-A1 | HYDROLYTICALLY STABLE RESINS FOR USE IN ANION-EXCHANGE CHROMATOGRAPHY | DIONEX CORPORATION (US) | 1998-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12134089-B2 | Multimodal chromatographic media for protein separation | MAX, NEFM, MRPL21 | ALDH1A1 4833/4885TSHR 3975/4885TP53 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.